Delivery Order SPE2DR25D2012-SPE2DR26F1BPK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,799.68 to AmerisourceBergen Drug Corp for Glimepiride 1 mg tablets in quantities of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Glimepiride is an oral medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,130.48 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Glimepiride 4 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside procurement. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,201.03 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 2 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $6,453.34. The delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $3,171.47 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $9,638.98 delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BPKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 1 mg tablets (100-count units) under a firm fixed-price contract valued at $2,065.08. The contract was competitively awarded without set-aside provisions and is scheduled for completion by December 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction within the company's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and related healthcare commodities to support military and federal healthcare systems worldwide. The Glimepiride order fulfills medical supply needs consistent with the broader contract's scope, which encompasses diabetes medications, specialty pharmaceuticals, and other critical medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/17/25 |